Synergistic Effect of Colistin Combined with PFK-158 against Colistin-Resistant Enterobacteriaceae

As increasing numbers of colistin-resistant bacteria emerge, new therapies are urgently needed to treat infections caused by these pathogens. The discovery of new combination therapies is one important way to solve such problems. Here, we report that the antitumor drug PFK-158 and its analogs PFK-01...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Antimicrob Agents Chemother
Päätekijät: Zhang, Youwen, Wang, Xiukun, Li, Xue, Dong, Limin, Hu, Xinxin, Nie, Tongying, Lu, Yun, Lu, Xi, Pang, Jing, Li, Guoqing, Yang, Xinyi, Li, Congran, You, Xuefu
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society for Microbiology 2019
Aiheet:
Experimental Therapeutics
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6591609/
https://ncbi.nlm.nih.gov/pubmed/30988150
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00271-19
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia